NDAIONTOPHORESIS, TRANSDERMALSYSTEM
Approved
May 2006
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2
Data completeness
3/8 — Basic
Drug data last refreshed 31m ago · AI intelligence enriched 31m ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IONSYS is a transdermal iontophoretic system delivering fentanyl hydrochloride for acute postoperative pain management. It uses electrical current to facilitate on-demand transdermal drug delivery, allowing patients to self-administer doses within programmed safety limits. The product represents an innovative delivery mechanism for opioid pain control in hospital settings.
Peak6.4 years to LOE
Product is in peak lifecycle stage with 6.4 years of patent exclusivity remaining, suggesting continued commercial investment in brand protection and hospital channel management.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Interruptions in the Coagulationsystem in Relation With Cardiac Surgery - A Study Comparing Two Heparinization Strategies During On-pump Cardiac Surgery
Started Nov 2011
0Cardiac Surgery
An Efficacy and Safety Study to Compare Fentanyl Ionsys and Routine Care With Intravenous (IV) Morphine Patient-controlled Analgesia (PCA) in Participants Who Have Undergone Elective Major Abdominal or Orthopedic Surgery
Started May 2008
108 enrolled
Pain, Postoperative
Career Relevance
IONSYS offers limited immediate job pipeline visibility (0 linked positions), but roles would center on hospital channel management, clinician education, and payer strategy for acute care settings. Career impact is strongest for professionals with hospital/acute care sales expertise and those focused on specialty delivery technology and LOE strategy development.
Worked on IONSYS at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.